Robot-assisted surgery for bleeding in the brain's chambers
Part of Brain & nervous system clinical trials.
This trial tests a minimally invasive robot-assisted surgery to remove bleeding inside the brain's fluid-filled spaces, which can happen after a stroke or injury. It aims to improve recovery by clearing the blood and reducing pressure on the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have had bleeding inside your brain's chambers (intraventricular hemorrhage) confirmed on a CT scan within 24 hours of symptoms starting.
- The bleeding must be severe enough, with a score of 8 or higher on a special scale, and at least 5 points from the two side chambers.
- If you also have bleeding in the brain tissue, the volume must be less than 30 mL.
- You need to have surgery within 72 hours of the first CT scan, and your level of consciousness (GCS) must be 14 or lower.
- You cannot have other causes of bleeding like an aneurysm, Moyamoya disease, or a brain tumor, and you must not have severe blood clotting problems or be on certain blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, less invasive surgery using a robot to help guide the doctor to drain blood from a brainstem bleed. It may be an option for people who can have surgery soon after the bleed and who have a certain level of consciousness.
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
This trial tests a new, less invasive brain surgery using a robotic arm guided by artificial intelligence (AI) to remove a large blood clot caused by a hemorrhagic stroke in the basal ganglia. It may be an option for people who can have surgery soon after the stroke and were previously independent.
This study tests a robot-assisted procedure to remove bleeding in the brain that happens after stroke treatment. The procedure uses a small tube to drain the blood, and a clot-busting drug (tenecteplase) may be injected to help break up the clot. It aims to reduce pressure in the brain and improve recovery.
This trial tests a minimally invasive surgery guided by artificial intelligence to treat spontaneous brain bleeding. It aims to improve recovery by precisely removing the clot with less damage to healthy brain tissue.
This trial uses a robot to assist with brain blood vessel treatments, like checking for blockages, treating tumors, or removing clots. It may help make these procedures more precise and safer.
Hear when a new Clarify the Therapeutic Differences Between Robot Assisted Endoscopic Clearance and Traditional Puncture and External Drainag trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.